Grail Stock Is Up 80% Over the Past Month. Here's Why.

Grail (NASDAQ: GRAL) has soared 80% over the past month. That's an incredible gain in a market that's climbed under 1% over that period as measured by the broader S&P 500 index. So what's happening?Well, Grail makes a multicancer early-detection test called Galleri that screens for a signal in the blood shared by more than 50 types of cancer. Cancers growing in the human body shed their DNA into the bloodstream, and the Galleri test can detect that DNA very early on -- often early enough for effective treatment.If that sounds like an incredible innovation in the world of cancer detection, that's because it is. But investors need to know if the test works and if Grail has the funds to effectively market and sell it.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool